Myriad Genetics Partners With Gabbi To Offer Breast Cancer Risk Assessment & Care Solution
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Myriad Genetics Inc. (MYGN) said that it has entered into a partnership with Gabbi, a telehealth platform specializing in breast cancer risk assessment and specialist care. The companies aim to deliver a comprehensive solution that integrates Gabbi’s risk assessment p
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2107841922-5be74c310a4d436a84276f5c123b69fc.jpg "The Surprising Truth About 60-Year-Olds’ 401(k) Balances in Today’s Market")